Home » Authors » Anette Breindl

Articles by Anette Breindl

From The Benches, First Hints On What Could Be ASCO 2012

June 5, 2007

By Anette Breindl

From The Benches, First Hints On What Could Be ASCO 2012

June 5, 2007

By Anette Breindl

Kinase Influences Learning, But Not Via Phosphorylation

June 1, 2007

By Anette Breindl

Kinase Influences Learning, But Not Via Phosphorylation

June 1, 2007

By Anette Breindl

Gene Therapy Restores Vision In Mouse Model Of Achromatopsia

May 31, 2007

By Anette Breindl

Gene Therapy Restores Vision In Mouse Model Of Achromatopsia

May 31, 2007

By Anette Breindl

Genetically Engineered Crop For Sustainable Agriculture Practice

May 29, 2007

By Anette Breindl

New Neurons In Adult Brain Can Aid Memory, If Correctly Wired

May 29, 2007

By Trista Morrison and Anette Breindl

Genetically Engineered Crop For Sustainable Agriculture Practice

May 29, 2007

By Anette Breindl

New Alzheimer's Avenues In Targeting Of Amyloid, Tau

May 23, 2007

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 9, 2025
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...
Australia’s Celosia heads toward clinic with gene therapy for ALS
BioWorld
After raising AU$16.75 million (US$10.4 million) in a series A round, Celosia Therapeutics Pty Ltd. is heading toward the clinic with its novel gene therapy that...
Sangamo stock plunges as Pfizer leaves hemophilia partnership
BioWorld
Sangamo Therapeutics Inc.’s stock sank sharply on the last day of 2025 as Pfizer Inc. handed back the rights to their collaborative gene therapy hemophilia A...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.